Truace
Subscribe

Review of 127 studies links AI in drug research and care to bias, privacy and trust risks

Study title: Artificial intelligence and machine learning in pharmaceutical research and healthcare: Ethical challenges and a framework for responsible implementation

By July 2026, a narrative review of 127 peer-reviewed studies from 2015-2026 examined how AI and ML are being used in pharmaceutical research and healthcare. The review found the technologies enable large-scale biomedical data analysis and data-driven decision-making while simultaneously introducing interconnected ethical challenges.

Read the study abstract

Background Artificial intelligence (AI) and machine learning (ML) are transforming pharmaceutical research and healthcare by enabling analysis of large-scale biomedical data and supporting data-driven decision-making. However, their rapid integration has introduced significant ethical, governance, and implementation challenges that remain insufficiently synthesized within a unified framework. Objective This work aims to synthesize the central ethical challenges and paradoxes associated with AI and ML in pharmace…

By the Truvace desk1 min read1 sourceEvidence: Emerging · 30/100 — Commentary, opinion, or narrative review · 1 independent sourcePeer-reviewedTRV-2026-0578· cite & verify
Artificial intelligence and machine learning in pharmaceutical research and healthcare: Ethical challenges and a framework for responsible implementation
Nota d'ètica en vermell by Culturaactiva. CC BY-SA 4.0 · https://creativecommons.org/licenses/by-sa/4.0

In brief

The work matters because it connects documented risks to patient safety and trust, such as bias, accountability, privacy, and equity concerns, to a practical governance response. Uncertainty remains about how the proposed three-pillar framework will perform in real clinical practice and policy settings, as the source presents a synthesis and framework rather than measured implementation outcomes.

Main points

  1. Narrative review screened PubMed/MEDLINE and Google Scholar from January 2015 to February 2026 and synthesized 127 studies.
  2. Literature clustered across pharmaceutical research, clinical decision support, and governance domains.
  3. Authors propose three-pillar ethics-centered framework: technical excellence and safety, robust governance and trust, and human-centered values with cross-cutting enablers.

The gain

AI and ML improved pharmaceutical research and healthcare capacity by enabling large-scale biomedical data analysis and data-driven decision-making.

The problem

Rapid integration of AI/ML introduced interconnected ethical challenges around bias, accountability, privacy, and equity that affect patient safety and trust.

The rundown

The authors conducted a narrative review of peer-reviewed English-language publications from January 2015 to February 2026, screening PubMed/MEDLINE and Google Scholar and thematically synthesizing 127 studies.

Synthesis identified clustered evidence across pharmaceutical research, clinical decision support, and governance, leading to a structured framework linking technical excellence and safety, governance and trust, and human-centered values to guide trustworthy implementation.

Sources

  1. Peer-reviewedJournal of the American Pharmacists Association2026-07-24

The debate